Quidel | QDEL - Cost Of Sales


Quidel reported $407M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Agilent USD 845M 7M Mar/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Bruker USD 422.5M 21.1M Jun/2026
Cerus USD 23.42M 3.61M Dec/2024
Charles River Laboratories USD 655.29M 61.22M Jun/2026
Danaher USD 2.65B 294M Jun/2026
Haemonetics USD 136.58M 11.56M Jun/2026
Illumina USD 389M 19M Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Merit Medical Systems USD 203.68M 6.6M Jun/2026
Mettler Toledo International USD 396.52M 14.4M Jun/2026
Myriad Genetics USD 63M 1.1M Dec/2025
Neogen USD 117.5M 5.3M Mar/2026
OraSure Technologies USD 15.43M 113K Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quidel USD 407M 486.5M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
STAAR Surgical USD 24.66M 10.6M Mar/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Waters USD 1.16B 430M Jun/2026